Kaibiao Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kaibiao Xu has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Yafang Hu
Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China
12 shared publications - Guanghui Liu
Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China
10 shared publications - Guoxin Li
Department of General Surgery, Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
10 shared publications - Hao Liu
Department of General Surgery & Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, Southern Medical University, Guangzhou, China
10 shared publications - Jingsi Liu
Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, China
10 shared publications - Qianhui Zheng
Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China
10 shared publications
Latest Publications
- Open Access
Glymphatic System Is Enhanced in Anti-NMDAR Encephalitis and Facilitates Antibody Influx and Clearance in the Brain
Background: Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is an antibody-mediated neuroinflammatory disease. How pathogenic autoantibodies enter and are cleared from the brain parenchyma remains poorly understood. The glymphatic system (GS) mediates cerebrospinal fluid (CSF)-interstitial fluid (ISF) exchange and waste removal, yet its role in anti-NMDAR encephalitis is undefined. Methods: We used polypeptides GluN1 356-385 induced active-immunization anti-NMDAR encephalitis mouse model. Glymphatic influx and efflux were evaluated via fluorescent tracer delivery combined with real-time imaging and ex-vivo quantification. Perivascular aquaporin-4 (AQP4) polarization, brain IgG deposition, NMDAR levels and blood-brain barrier (BBB) integrity were analyzed. GS function was pharmacologically modulated with AER-271 (an AQP4 inhibitor) or dexmedetomidine (Dex), and deep cervical lymphatic vessels (dCLV) were ligated in a passive-transfer model (PTM). Behavioral performance was characterized by multiple neurobehavioral tests. Results: Both glymphatic influx and efflux were enhanced in anti-NMDAR encephalitis mice, accompanied by upregulated antibody entry into and clearance from the brain. However, the cerebral IgG deposition was increased. These changes were associated with increased perivascular AQP4 polarization, with no alterations in overall AQP4 abundance or BBB tight-junction integrity. AQP4 inhibition with AER-271 attenuated glymphatic influx and efflux, reduced hippocampus IgG deposition, and partially ameliorated behavioral deficits without restoring hippocampus NMDAR levels. Conversely, dCLV ligation in the PTM mice increased brain retention of patient-derived IgG and exacerbated anxiety-like behavior. Dex enhanced antibody clearance and reduced hippocampus IgG deposition but did not improve behavioral outcomes. Conclusion: The GS is dynamically upregulated in anti-NMDAR encephalitis, driven by increased perivascular AQP4 polarization. The enhanced glymphatic influx facilitates antibody entry into the brain parenchyma and exacerbates neuronal injury, whereas enhanced efflux provides a compensatory route for antibody clearance. Rather than broadly enhancing glymphatic activity, precise tuning of this pathway may present a promising non-immunological therapeutic strategy for autoimmune encephalitis.
Open AccessGlymphatic System Is Enhanced in Anti-NMDAR Encephalitis and Facilitates Antibody Influx and Clearance in the Brain
Background: Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is an antibody-mediated neuroinflammatory disease. How pathogenic autoantibodies enter and are cleared from the brain parenchyma remains poorly understood. The glymphatic system (GS) mediates cerebrospinal fluid (CSF)-interstitial fluid (ISF) exchange and waste removal, yet its role in anti-NMDAR encephalitis is undefined. Methods: We used polypeptides GluN1 356-385 induced active-immunization anti-NMDAR encephalitis mouse model. Glymphatic influx and efflux were evaluated via fluorescent tracer delivery combined with real-time imaging and ex-vivo quantification. Perivascular aquaporin-4 (AQP4) polarization, brain IgG deposition, NMDAR levels and blood-brain barrier (BBB) integrity were analyzed. GS function was pharmacologically modulated with AER-271 (an AQP4 inhibitor) or dexmedetomidine (Dex), and deep cervical lymphatic vessels (dCLV) were ligated in a passive-transfer model (PTM). Behavioral performance was characterized by multiple neurobehavioral tests. Results: Both glymphatic influx and efflux were enhanced in anti-NMDAR encephalitis mice, accompanied by upregulated antibody entry into and clearance from the brain. However, the cerebral IgG deposition was increased. These changes were associated with increased perivascular AQP4 polarization, with no alterations in overall AQP4 abundance or BBB tight-junction integrity. AQP4 inhibition with AER-271 attenuated glymphatic influx and efflux, reduced hippocampus IgG deposition, and partially ameliorated behavioral deficits without restoring hippocampus NMDAR levels. Conversely, dCLV ligation in the PTM mice increased brain retention of patient-derived IgG and exacerbated anxiety-like behavior. Dex enhanced antibody clearance and reduced hippocampus IgG deposition but did not improve behavioral outcomes. Conclusion: The GS is dynamically upregulated in anti-NMDAR encephalitis, driven by increased perivascular AQP4 polarization. The enhanced glymphatic influx facilitates antibody entry into the brain parenchyma and exacerbates neuronal injury, whereas enhanced efflux provides a compensatory route for antibody clearance. Rather than broadly enhancing glymphatic activity, precise tuning of this pathway may present a promising non-immunological therapeutic strategy for autoimmune encephalitis.
- Open Access
- 25 August 2026
- Published by Springer Nature in BMC Neurology
- Vol. 26 (1)
Glymphatic system dysfunction in anti-NMDAR encephalitis: a comparative DTI-ALPS study with healthy controls and epilepsy patients
- 25 August 2026
- Published by Springer Nature in BMC Neurology
- Vol. 26 (1)
Open AccessGlymphatic system dysfunction in anti-NMDAR encephalitis: a comparative DTI-ALPS study with healthy controls and epilepsy patients
- Open Access
- 3 December 2025
- Published by American Association for Cancer Research (AACR)
Figure 5 from Association of Neuronal Autoantibodies with Overall Survival in Patients with Gastric Cancer
Gene Ontology enrichment analysis of differentially expressed genes in TBA-positive vs. TBA-negative gastric cancer cells.
- 3 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 5 from Association of Neuronal Autoantibodies with Overall Survival in Patients with Gastric Cancer
Gene Ontology enrichment analysis of differentially expressed genes in TBA-positive vs. TBA-negative gastric cancer cells.
- Open Access
- 3 December 2025
- Published by American Association for Cancer Research (AACR)
Figure 3 from Association of Neuronal Autoantibodies with Overall Survival in Patients with Gastric Cancer
Kaplan–Meier survival curves for OS in TBA-positive and TBA-negative patients with gastric cancer.
- 3 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 3 from Association of Neuronal Autoantibodies with Overall Survival in Patients with Gastric Cancer
Kaplan–Meier survival curves for OS in TBA-positive and TBA-negative patients with gastric cancer.
- Open Access
- 3 December 2025
- Published by American Association for Cancer Research (AACR)
Figure 1 from Association of Neuronal Autoantibodies with Overall Survival in Patients with Gastric Cancer
Neuronal autoantibody staining patterns and identification of known PNS-related antibodies in patients with gastric cancer. Ab, antibody.
- 3 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 1 from Association of Neuronal Autoantibodies with Overall Survival in Patients with Gastric Cancer
Neuronal autoantibody staining patterns and identification of known PNS-related antibodies in patients with gastric cancer. Ab, antibody.
- Open Access
- 3 December 2025
- Published by American Association for Cancer Research (AACR)
Figure 2 from Association of Neuronal Autoantibodies with Overall Survival in Patients with Gastric Cancer
Reduced CD8+ T-cell infiltration and altered CD4+/CD8+ ratio in TBA-positive gastric cancer tissues. ns, not significant.
- 3 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 2 from Association of Neuronal Autoantibodies with Overall Survival in Patients with Gastric Cancer
Reduced CD8+ T-cell infiltration and altered CD4+/CD8+ ratio in TBA-positive gastric cancer tissues. ns, not significant.
- Open Access
- 3 December 2025
- Published by American Association for Cancer Research (AACR)
Data from Association of Neuronal Autoantibodies with Overall Survival in Patients with Gastric Cancer
Neuronal autoantibodies have been identified in immune-mediated encephalitis, most of which are related to paraneoplastic neurologic syndromes (PNS). We detected neuronal autoantibodies in patients with gastric cancer without PNS and illustrated their correlation with clinical prognosis. All serum samples were tested by the mouse brain tissue-based assay (TBA) using immunofluorescence for screening neuronal autoantibodies. Known PNS-related neuronal autoantibodies were detected by cell-based assay. A single-center cohort has been started in Nanfang Hospital. The T-cell status of the tumor microenvironment was assessed. Single-cell sequencing was performed with limited tumor samples. Patients were grouped into TBA-positive (n = 144) and TBA-negative (n = 179) groups by the TBA status. Further screening of TBA+ specimens using the cell-based assay method revealed known PNS-related autoantibodies in 13.2% (19/144) of cases. Additionally, TBA-positive patients with gastric cancer exhibited lower CD8+ T-cell infiltration in the tumor tissue. The survival analysis show that neuronal autoantibodies in patients (TBA-positive) were associated with shorter overall survival (OS; P = 0.014). In the multivariate survival analysis, TBA positivity was still associated with shortened OS after adjusting the major covariates (HR = 2.28; 95% confidence interval, 1.31–3.97; P = 0.004). Meanwhile, single-cell sequencing indicates that cell junction assembly and synapse organization may play important roles in biological process. In this cohort study, neuronal autoantibodies were highly prevalent among patients with gastric cancer and were associated with shortened OS and features of immunosuppression within the tumor microenvironment, suggesting a candidate for exploring therapeutic relevance, with further mechanistic studies needed for validation.Significance:Neuronal autoantibodies are prevalent in patients with gastric cancer, and patients without neurologic symptoms are linked to shorter survival and immunosuppression. These results provide a new direction for prognostic biomarkers and targeted therapy exploration.
- 3 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Association of Neuronal Autoantibodies with Overall Survival in Patients with Gastric Cancer
Neuronal autoantibodies have been identified in immune-mediated encephalitis, most of which are related to paraneoplastic neurologic syndromes (PNS). We detected neuronal autoantibodies in patients with gastric cancer without PNS and illustrated their correlation with clinical prognosis. All serum samples were tested by the mouse brain tissue-based assay (TBA) using immunofluorescence for screening neuronal autoantibodies. Known PNS-related neuronal autoantibodies were detected by cell-based assay. A single-center cohort has been started in Nanfang Hospital. The T-cell status of the tumor microenvironment was assessed. Single-cell sequencing was performed with limited tumor samples. Patients were grouped into TBA-positive (n = 144) and TBA-negative (n = 179) groups by the TBA status. Further screening of TBA+ specimens using the cell-based assay method revealed known PNS-related autoantibodies in 13.2% (19/144) of cases. Additionally, TBA-positive patients with gastric cancer exhibited lower CD8+ T-cell infiltration in the tumor tissue. The survival analysis show that neuronal autoantibodies in patients (TBA-positive) were associated with shorter overall survival (OS; P = 0.014). In the multivariate survival analysis, TBA positivity was still associated with shortened OS after adjusting the major covariates (HR = 2.28; 95% confidence interval, 1.31–3.97; P = 0.004). Meanwhile, single-cell sequencing indicates that cell junction assembly and synapse organization may play important roles in biological process. In this cohort study, neuronal autoantibodies were highly prevalent among patients with gastric cancer and were associated with shortened OS and features of immunosuppression within the tumor microenvironment, suggesting a candidate for exploring therapeutic relevance, with further mechanistic studies needed for validation.Significance:Neuronal autoantibodies are prevalent in patients with gastric cancer, and patients without neurologic symptoms are linked to shorter survival and immunosuppression. These results provide a new direction for prognostic biomarkers and targeted therapy exploration.
- Open Access
- 3 December 2025
- Published by American Association for Cancer Research (AACR)
Table 2 from Association of Neuronal Autoantibodies with Overall Survival in Patients with Gastric Cancer
Cox proportional hazards regression analysis of factors affecting OS in patients with gastric cancer.
- 3 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable 2 from Association of Neuronal Autoantibodies with Overall Survival in Patients with Gastric Cancer
Cox proportional hazards regression analysis of factors affecting OS in patients with gastric cancer.
- Open Access
- 3 December 2025
- Published by American Association for Cancer Research (AACR)
Figure 4 from Association of Neuronal Autoantibodies with Overall Survival in Patients with Gastric Cancer
Comparison of 3-year OS among TBA-negative, CBA-positive, and TBA-positive CBA-negative groups.
- 3 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 4 from Association of Neuronal Autoantibodies with Overall Survival in Patients with Gastric Cancer
Comparison of 3-year OS among TBA-negative, CBA-positive, and TBA-positive CBA-negative groups.